Abstracts tagged "Nephritis and systemic lupus erythematosus (SLE)"

Abstract Number: 641 • 2014 ACR/ARHP Annual Meeting
Peptidylarginine Deiminase Inhibition Mitigates NET Formation and Protects Against Kidney, Skin, and Vascular Disease in Lupus-Prone MRL/Lpr Mice
Jason S. Knight¹, Venkataraman Subramanian², Alexander A. O'Dell¹, Srilakshmi Yalavarthi¹, Wenpu Zhao³, Carolyne K. Smith³, Jeffrey B. Hodgin⁴, Paul Thompson² and Mariana J. Kaplan³, ¹Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, ²The Scripps Research Institute, Jupiter, FL, ³Systemic Autoimmunity Branch, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, ⁴Department of Pathology, University of Michigan, Ann Arbor, MI
Background/Purpose: An imbalance between neutrophil extracellular trap (NET) production and NET degradation has been observed in systemic lupus erythematosus (SLE), potentially contributing to autoantigen externalization,…
Abstract Number: 2898 • 2013 ACR/ARHP Annual Meeting
Atherosclerosis In Systemic Lupus Erythematosus (SLE) and Controls, -An Analysis Of SLE Subgroups
Johanna Gustafsson¹, Kerstin Jensen-Urstad², Marie Herlitz-Lindberg², Sonia Möller¹, Susanne Pettersson¹, Iva Gunnarsson¹, Anders Larsson³ and Elisabet Svenungsson⁴, ¹Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, ²Department of Clinical Physiology, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden, ³Department of Clinical Chemistry and Pharmacology, Akademiska Hospital, Uppsala, Sweden, ⁴Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Stockholm, Sweden
Background/Purpose: Atherosclerosis is often assumed to be the main underlying cause of premature vascular events (VE) among patients with systemic lupus erythematosus (SLE) and accelerated…
Abstract Number: 602 • 2013 ACR/ARHP Annual Meeting
Repeat Biopsy In Lupus Nephritis: A Single-Center Experience
Josefina Marin¹, Marina Scolnik², Eliana Lancioni³, Gustavo Greloni⁴, Cristian Quiroz⁵, Johana Zacariaz³, Carla Saucedo⁶, Luis J. Catoggio² and Enrique R. Soriano², ¹Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ²Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, ³Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ⁴Nephrology Service. Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ⁵Internal Medicine, Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ⁶Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Background/Purpose: Renal involvement in systemic lupus erythematosus (SLE) is an important cause of morbidity and even mortality. Lupus nephritis has diverse morphologic manifestations with varying clinical…
Abstract Number: 2239 • 2012 ACR/ARHP Annual Meeting
Characterization of Pure Membranous Lupus Nephritis: A Cohort of 150 Patients
Lucía Silva¹, Teresa Oton¹, Anca Askanase², Patricia Carreira³, Francisco Javier López-Longo⁴, Anne Riveros⁵, Íñigo Rúa-Figueroa⁶, Javier Narvaez⁷, Esther Ruiz-Lucea⁸, Mariano Andres⁹, Enrique Calvo¹⁰, Francisco Toyos¹¹, Juan J. Alegre¹², Eva Tomero¹³, Carlos Montilla¹⁴, Antonio Zea¹⁵, Esther Uriarte-Isacelaya¹⁶, Jaime Calvo-Alen¹⁷, Carlos Marras¹⁸, Víctor M. Martínez-Taboada¹⁹, María Ángeles Belmonte²⁰, Jose Rosas²¹, Enrique Raya²², Gema Bonilla²³ and Mercedes Freire²⁴, ¹Rheumatology, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Madrid), Spain, ²NYU School of Medicine, New York, NY, ³Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, ⁴Hospital General Universitario Gregorio Marañón, Department of Rheumatology, Madrid, Spain, ⁵Rheumatology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, ⁶Rheumatology, Hospital Universitario Dr Negrín. Las Palmas, Las Palmas de Gran Canaria, Spain, ⁷Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, ⁸Rheumatology, Hospital de Basurto, Bilbao, Spain, ⁹Seccion Reumatologia, Hospital General Universitario de Alicante, Alicante, Spain, ¹⁰Rheumatology, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Spain, ¹¹Rheumatology, Hospital Universitario Virgen Macarena, Sevilla, Spain, ¹²Rheumatology, Hospital Universitario Dr Peset, Valencia, Spain, ¹³Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, ¹⁴Unit Rheumatology, Hospital Universitario de Salamanca, Salamanca, Spain, ¹⁵Rheumatology, Hospital Universitario Ramon y Cajal, Madrid, Spain, ¹⁶Rheumatology, Hospital Universitario de Donostia, Donosti, Spain, ¹⁷Rheumatology, Hospital Sierrallana. Torrelavega, Torrelavega, Spain, ¹⁸Rheumatology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain, ¹⁹Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV, Santander, Spain, ²⁰Rheumatology, Hospital Universitario Carlos Haya, Málaga, Spain, ²¹Rheumatology, Hospital Marina Baixa. Villajoyosa, Villajoyosa, Spain, ²²Rheumatology, University Hospital San Cecilio, Granada, Spain, ²³Rheumatology, Hospital La Paz, Madrid, Spain, ²⁴Rheumatology, Hospital Universitario Juan Canalejo, La Coruña, Spain
Background/Purpose : Over 50% of patients with SLE develop renal involvement but only 20% of these are found to have pure membranous lupus neprhitis (MLN)…
Abstract Number: 1445 • 2012 ACR/ARHP Annual Meeting
Shared and Unique Molecular Features of Nephritis in 3 Models of Murine SLE
Ramalingam Bethunaickan¹, Celine C. Berthier², Matthias Kretzler³ and Anne Davidson⁴, ¹Autoimmunity, Feinstein Institute for Medical Research, Manhasset, NY, ²Nephrology, University of Michigan, Ann Arbor, MI, ³Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, MI, ⁴Autoimmunity and Musculoskeletal Diseases, Feinstein Institute for Medical Research, Manhasset, NY
Background/Purpose: Mouse models are useful for studying the pathogenesis of SLE nephritis but it is not clear which model is the most appropriate for understanding…
Abstract Number: 1454 • 2012 ACR/ARHP Annual Meeting
Characterization of Renal Mononuclear Phagocyte Populations in Murine SLE Nephritis
Ranjit Sahu¹, Ramalingam Bethunaickan² and Anne Davidson¹, ¹Autoimmunity and Musculoskeletal Diseases, Feinstein Institute for Medical Research, Manhasset, NY, ²Autoimmunity, Feinstein Institute for Medical Research, Manhasset, NY
Background/Purpose: Macrophages and dendritic cells contribute to renal damage in chronic renal diseases including lupus nephritis. However owing to their multiple phenotypic and functional variations,…
Abstract Number: 608 • 2012 ACR/ARHP Annual Meeting
Association of Discoid Lupus with Other Clinical Manifestations Among Patients with Systemic Lupus Erythematosus
Joseph F. Merola¹, Christina Iversen², Jose A. Gomez-Puerta², Tabatha Norton², Hsun Tsao², Peter H. Schur², Elena M. Massarotti², Bonnie L. Bermas³ and Karen H. Costenbader², ¹Rheumatology, Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ²Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ³Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Prior studies suggest that cutaneous discoid lupus (DLE) is a marker for less severe disease with a low frequency of nephritis and end-stage renal…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].